We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Phototherapy Treats Skin Disorders

By HospiMedica staff writers
Posted on 21 Jan 2004
A computer-controlled, targeted phototherapy system developed by Israeli researchers utilizes both ultraviolet-b (UVB) and ultraviolet-a (UVA) rays to treat psoriasis and other skin disorders. More...
The system has been cleared by the U.S. Food and Drug Administration (FDA).

Called MultiClear, the system is the first computer-controlled phototherapy system to utilize both UVB and UVA rays. The system has proven safe and effective for treating psoriasis, vitiligo, atopic dermatitis, and leukoderma. MultiClear is manufactured by CureLight Ltd. (Or Akiva, Israel), which sees it as a nondrug alternative that protects patients from exposing their entire bodies to potentially harsh or risky treatments.

"It's safe, responsive, and gets good aesthetic results as well,” said Dr. David J. Friedman, a dermatologist and former assistant professor at Brown University (Providence, RI, USA), who uses MultiClear for his patients. "Typical treatment lasts about five minutes and that's another real plus. Usually less than 10 treatments are needed.”


Related Links:
CureLight

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.